mTOR pathway as a potential therapeutic target for cancer stem cells in canine mammary carcinoma. Michishita M, Ochiai K, Nakahira R, Azakami D, Machida Y, Nagashima T, Nakagawa T, Ishiwata T.Front Oncol. 2023 Jan 27;13:1100602. https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1100602/full